Du W, Noyan F, McCallion O, Drosdek V, Kath J, Glaser V
Mol Ther. 2025; 33(3):997-1013.
PMID: 39905729
PMC: 11897813.
DOI: 10.1016/j.ymthe.2025.01.045.
Nguyen J, Jessri M, Costa-da-Silva A, Sharma R, Mays J, Treister N
Int J Mol Sci. 2024; 25(19).
PMID: 39408739
PMC: 11476840.
DOI: 10.3390/ijms251910411.
Braidotti S, Granzotto M, Curci D, Kotnik B, Maximova N
Biomedicines. 2024; 12(8).
PMID: 39200317
PMC: 11351482.
DOI: 10.3390/biomedicines12081853.
Pacini C, Soares M, Lacerda J
Front Immunol. 2024; 15:1339318.
PMID: 38711496
PMC: 11070504.
DOI: 10.3389/fimmu.2024.1339318.
Kuroiwa K, Sato M, Narita H, Okamura R, Uesugi Y, Sasaki Y
Int J Hematol. 2024; 119(5):583-591.
PMID: 38418747
DOI: 10.1007/s12185-024-03726-y.
Gut microbiota, microbiota-derived metabolites, and graft-versus-host disease.
Yue X, Zhou H, Wang S, Chen X, Xiao H
Cancer Med. 2024; 13(3):e6799.
PMID: 38239049
PMC: 10905340.
DOI: 10.1002/cam4.6799.
Dissecting the regulatory network of transcription factors in T cell phenotype/functioning during GVHD and GVT.
Harris R, Karimi M
Front Immunol. 2023; 14:1194984.
PMID: 37441063
PMC: 10333690.
DOI: 10.3389/fimmu.2023.1194984.
Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers.
Bojanic I, Worel N, Pacini C, Stary G, Piekarska A, Flinn A
Front Immunol. 2023; 14:1086006.
PMID: 36875063
PMC: 9981637.
DOI: 10.3389/fimmu.2023.1086006.
Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD.
Buxbaum N, Socie G, Hill G, MacDonald K, Tkachev V, Teshima T
Blood Adv. 2022; 7(17):4886-4902.
PMID: 36322878
PMC: 10463203.
DOI: 10.1182/bloodadvances.2022007611.
Inhibition of FOXP3 by stapled alpha-helical peptides dampens regulatory T cell function.
Hawley K, Eclov R, Schnorenberg M, Tian Y, Shah R, Thomas-Toth A
Proc Natl Acad Sci U S A. 2022; 119(42):e2209044119.
PMID: 36227917
PMC: 9586281.
DOI: 10.1073/pnas.2209044119.
T Helper Cell Lineage-Defining Transcription Factors: Potent Targets for Specific GVHD Therapy?.
Campe J, Ullrich E
Front Immunol. 2022; 12:806529.
PMID: 35069590
PMC: 8766661.
DOI: 10.3389/fimmu.2021.806529.
XBP-1s Promotes B Cell Pathogenicity in Chronic GVHD by Restraining the Activity of Regulated IRE-1α-Dependent Decay.
Choi H, Tang C, Tian L, Wu Y, Sofi M, Ticer T
Front Immunol. 2021; 12:705484.
PMID: 34659198
PMC: 8517405.
DOI: 10.3389/fimmu.2021.705484.
Harnessing Treg Homeostasis to Optimize Posttransplant Immunity: Current Concepts and Future Perspectives.
Ikegawa S, Matsuoka K
Front Immunol. 2021; 12:713358.
PMID: 34526990
PMC: 8435715.
DOI: 10.3389/fimmu.2021.713358.
Immune Reconstitution-Based Score for Risk Stratification of Chronic Graft-Versus-Host Disease Patients.
Serpenti F, Lorentino F, Marktel S, Milani R, Messina C, Greco R
Front Oncol. 2021; 11:705568.
PMID: 34367991
PMC: 8341942.
DOI: 10.3389/fonc.2021.705568.
Regulatory T Cells in GVHD Therapy.
Guo W, Su X, Wang M, Han M, Feng X, Jiang E
Front Immunol. 2021; 12:697854.
PMID: 34220860
PMC: 8250864.
DOI: 10.3389/fimmu.2021.697854.
High preharvest donor Foxp3 mRNA level predicts late relapse of acute lymphoblastic leukaemia after haematopoietic stem cell transplantation.
Jacobsen N, Frisch T, Keiding N, Heilmann C, Sengelov H, Madsen H
Eur J Haematol. 2021; 106(5):643-653.
PMID: 33527553
PMC: 8248440.
DOI: 10.1111/ejh.13591.
Decreased Foxp3 and function of Tregs caused immune imbalance and liver injury in patients with autoimmune liver diseases post-liver transplantation.
Liu Z, Gu J, Qin Z, Yang C, Yu S, Dai X
Ann Transl Med. 2020; 8(8):534.
PMID: 32411757
PMC: 7214902.
DOI: 10.21037/atm.2020.03.203.
Reduced-intensity haploidentical peripheral blood stem cell transplantation using low-dose thymoglobulin for aggressive adult T cell leukemia/lymphoma patients in non-complete remission.
Hirosawa M, Yamaguchi T, Tanaka A, Kominato Y, Higashi T, Morimoto H
Ann Hematol. 2020; 99(3):599-607.
PMID: 32006150
PMC: 7060159.
DOI: 10.1007/s00277-020-03934-6.
The promise of CD4FoxP3 regulatory T-cell manipulation : applications for allogeneic hematopoietic stem cell transplantation.
Copsel S, Wolf D, Komanduri K, Levy R
Haematologica. 2019; 104(7):1309-1321.
PMID: 31221786
PMC: 6601084.
DOI: 10.3324/haematol.2018.198838.
Therapeutic targets and emerging treatment options in gastrointestinal acute graft-versus-host disease.
Renteria A, Levine J, Ferrara J
Expert Opin Orphan Drugs. 2018; 4(5):469-484.
PMID: 30057862
PMC: 6059654.
DOI: 10.1517/21678707.2016.1166949.